4.7 Review

Metabolic, structural and biochemical changes in diabetes and the development of heart failure

Related references

Note: Only part of the references are listed.
Review Pharmacology & Pharmacy

One hundred years since insulin discovery: An update on current and future perspectives for pharmacotherapy of diabetes mellitus

Rajmohan Seetharaman et al.

Summary: The discovery and commercial availability of insulins revolutionized the treatment of diabetes mellitus. With the increasing prevalence of the disease, there is ongoing research and development of new drugs targeting novel mechanisms to improve efficacy and reduce adverse effects. Some of these newer drugs have shown promising results in recent clinical trials and may potentially change the landscape of diabetes treatment.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2022)

Article Cardiac & Cardiovascular Systems

The GLP-1 Receptor Agonist Liraglutide Increases Myocardial Glucose Oxidation Rates via Indirect Mechanisms and Mitigates Experimental Diabetic Cardiomyopathy

Malak Almutairi et al.

Summary: The study demonstrates that liraglutide indirectly augments myocardial glucose oxidation, potentially contributing to improved cardiovascular outcomes in people with type 2 diabetes.

CANADIAN JOURNAL OF CARDIOLOGY (2021)

Article Cardiac & Cardiovascular Systems

Targeting Mitochondria-Inflammation Circuit by β-Hydroxybutyrate Mitigates HFpEF

Yan Deng et al.

Summary: This study identified the interplay of mitochondrial hyperacetylation and inflammation as a key driver in HFpEF pathogenesis, and showed that increasing beta-hydroxybutyrate levels can ameliorate the disease by reducing inflammation and mitochondrial dysfunction.

CIRCULATION RESEARCH (2021)

Article Cardiac & Cardiovascular Systems

Impact of glycemic control on the association of endothelial dysfunction and coronary artery disease in patients with type 2 diabetes mellitus

Shuai Chen et al.

Summary: Poor glycemic control negatively influences the association of endothelial dysfunction and coronary artery disease in T2DM patients.

CARDIOVASCULAR DIABETOLOGY (2021)

Article Cardiac & Cardiovascular Systems

Cardiac Energy Metabolism in Heart Failure

Gary D. Lopaschuk et al.

Summary: Changes in cardiac energy metabolism are complex and depend on the severity and type of heart failure, as well as the presence of common comorbidities such as obesity and type 2 diabetes. The failing heart experiences an energy deficit due to decreased mitochondrial oxidative capacity, compensated for by increased ATP production from glycolysis. Alterations in mitochondrial ATP production fuels and fatty acid oxidation contribute to the inefficiency of the failing heart, with potential therapeutic targets in energy metabolic pathways to improve cardiac function.

CIRCULATION RESEARCH (2021)

Article Cell Biology

FoxO1 inhibition alleviates type 2 diabetes-related diastolic dysfunction by increasing myocardial pyruvate dehydrogenase activity

Keshav Gopal et al.

Summary: The study demonstrates that inhibition of FoxO1 improves diastolic dysfunction in diabetic cardiomyopathy by stimulating PDH activity. The interplay between FoxO1 inhibition and PDH activity plays a crucial role in improving cardiac function.

CELL REPORTS (2021)

Review Biochemistry & Molecular Biology

What Is the Mechanism Driving the Reduction of Cardiovascular Events from Glucagon-like Peptide-1 Receptor Agonists?-A Mini Review

Jared Berndt et al.

Summary: GLP-1 RAs are considered the standard of care for type 2 diabetes in many countries due to their strong anti-hyperglycemic effects and favorable safety profile. Recent CV outcome trials have shown that these molecules reduce major adverse cardiovascular events and improve surrogate markers associated with CV risk, prompting further research into their cardiovascular protective qualities.

MOLECULES (2021)

Article Cardiac & Cardiovascular Systems

Microvascular Disease and Incident Heart Failure Among Individuals With Type 2 Diabetes Mellitus

Arnaud D. Kaze et al.

Summary: The study found an association between microvascular disease (MVD) and an increased risk of heart failure (HF) in individuals with type 2 diabetes mellitus. Even after adjusting for other known risk factors, MVD remained significantly related to incident HF. Different types of MVD may have varying impacts on the development of HF.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)

Article Cardiac & Cardiovascular Systems

Extreme Acetylation of the Cardiac Mitochondrial Proteome Does Not Promote Heart Failure

Michael T. Davidson et al.

CIRCULATION RESEARCH (2020)

Article Cardiac & Cardiovascular Systems

O-GlcNAcylation Mediates Glucose-Induced Alterations in Endothelial Cell Phenotype in Human Diabetes Mellitus

Nobuyuki Masaki et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)

Article Cardiac & Cardiovascular Systems

Hyperglycemia Induces Myocardial Dysfunction via Epigenetic Regulation of JunD

Shafaat Hussain et al.

CIRCULATION RESEARCH (2020)

Review Cardiac & Cardiovascular Systems

Mechanisms of Cardiovascular Benefits of Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors A State-of-the-Art Review

Gary D. Lopaschuk et al.

JACC-BASIC TO TRANSLATIONAL SCIENCE (2020)

Article Multidisciplinary Sciences

Nitrosative stress drives heart failure with preserved ejection fraction

Gabriele G. Schiattarella et al.

NATURE (2019)

Article Cardiac & Cardiovascular Systems

DNA methylation reprograms cardiac metabolic gene expression in end-stage human heart failure

Mark E. Pepin et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2019)

Review Endocrinology & Metabolism

The epigenetic landscape in the cardiovascular complications of diabetes

S. Costantino et al.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2019)

Article Medicine, General & Internal

Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes

Aidin Rawshani et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Cardiac & Cardiovascular Systems

MicroRNA profiling unveils hyperglycaemic memory in the diabetic heart

Sarah Costantino et al.

EUROPEAN HEART JOURNAL (2016)

Article Biochemistry & Molecular Biology

Lipotoxicity in obesity and diabetes-related cardiac dysfunction

Igor Zlobine et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2016)

Article Medicine, General & Internal

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

Steven P. Marso et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Article Medicine, Research & Experimental

Mitochondrial protein hyperacetylation in the failing heart

Julie L. Horton et al.

JCI INSIGHT (2016)

Article Cardiac & Cardiovascular Systems

Histone deacetylase (HDAC) inhibition improves myocardial function and prevents cardiac remodeling in diabetic mice

Youfang Chen et al.

CARDIOVASCULAR DIABETOLOGY (2015)

Article Cardiac & Cardiovascular Systems

Mitochondrial complex I defect and increased fatty acid oxidation enhance protein lysine acetylation in the diabetic heart

Edwin J. Vazquez et al.

CARDIOVASCULAR RESEARCH (2015)

Article Medicine, General & Internal

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

Bernard Zinman et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Article Cardiac & Cardiovascular Systems

Obesity-induced lysine acetylation increases cardiac fatty acid oxidation and impairs insulin signalling

Osama Abo Alrob et al.

CARDIOVASCULAR RESEARCH (2014)

Article Cardiac & Cardiovascular Systems

Metabolic dysfunction in diabetic cardiomyopathy

Michael Isfort et al.

HEART FAILURE REVIEWS (2014)

Article Radiology, Nuclear Medicine & Medical Imaging

Effects of type 2 diabetes mellitus on coronary microvascular function and myocardial perfusion in patients without obstructive coronary artery disease

Caterina Marciano et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)

Article Cardiac & Cardiovascular Systems

Advanced glycation end-products in myocardium-supported vessels: Effects of heart failure and diabetes mellitus

Jerzy Nozynski et al.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2011)

Review Biochemistry & Molecular Biology

Lipotoxicity in the heart

Adam R. Wende et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2010)

Article Endocrinology & Metabolism

miR133a regulates cardiomyocyte hypertrophy in diabetes

Biao Feng et al.

DIABETES-METABOLISM RESEARCH AND REVIEWS (2010)

Article Medicine, Research & Experimental

Excessive cardiac insulin signaling exacerbates systolic dysfunction induced by pressure overload in rodents

Ippei Shimizu et al.

JOURNAL OF CLINICAL INVESTIGATION (2010)

Article Cardiac & Cardiovascular Systems

The Pathologic Continuum of Diabetic Vascular Disease

Gabriela Orasanu et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)

Article Cardiac & Cardiovascular Systems

Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathy

Sophie Van Linthout et al.

BASIC RESEARCH IN CARDIOLOGY (2008)

Article Physiology

Mechanisms of impaired calcium handling underlying subclinical diastolic dysfunction in diabetes

Veronique A. Lacombe et al.

AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2007)

Article Cardiac & Cardiovascular Systems

Diastolic dysfunction and diabetic cardiomyopathy - Evaluation by Doppler echocardiography

Maurizio Galderisi

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)

Article Cardiac & Cardiovascular Systems

The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy

J Asbun et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)

Review Biochemistry & Molecular Biology

Mediators of endoplasmic reticulum stress-induced apoptosis

Eva Szegezdi et al.

EMBO REPORTS (2006)

Article Endocrinology & Metabolism

The epidemiology of left ventricular hypertrophy in type 2 diabetes mellitus

A Dawson et al.

DIABETOLOGIA (2005)

Article Cardiac & Cardiovascular Systems

Adenovirus-mediated overexpression of O-GlcNAcase improves contractile function in the diabetic heart

Y Hu et al.

CIRCULATION RESEARCH (2005)

Review Endocrinology & Metabolism

Advanced glycation endproducts - role in pathology of diabetic complications

N Ahmed

DIABETES RESEARCH AND CLINICAL PRACTICE (2005)

Article Cardiac & Cardiovascular Systems

Defective intracellular Ca2+ signaling contributes to cardiomyopathy in Type 1 diabetic rats

KM Choi et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2002)

Review Multidisciplinary Sciences

Biochemistry and molecular cell biology of diabetic complications

M Brownlee

NATURE (2001)

Article Cardiac & Cardiovascular Systems

The impact of diabetes on left ventricular filling pattern in normotensive and hypertensive adults: The strong heart study

JE Liu et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)

Article Biochemistry & Molecular Biology

Palmitate-induced apoptosis can occur through a ceramide-independent pathway

LL Listenberger et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2001)

Article Cardiac & Cardiovascular Systems

Streptozotocin-induced changes in cardiac gene expression in the absence of severe contractile dysfunction

C Depre et al.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2000)

Article Multidisciplinary Sciences

Lipotoxic heart disease in obese rats: Implications for human obesity

YT Zhou et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)